ClinicalTrials.gov
ClinicalTrials.gov Menu

Fluoride Administered and Retained After Topical Fluoride Varnish

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01754831
Recruitment Status : Completed
First Posted : December 21, 2012
Last Update Posted : May 7, 2018
Sponsor:
Information provided by (Responsible Party):
Peter Milgrom, University of Washington

Brief Summary:
The specific aim of the study is to determine the excess urinary fluoride and its time course after administration of an application of Premier Enamel Pro Varnish to the teeth of 12-15 month old infants. From these data the investigators can estimate the bioavailable (more precisely the equivalent) dose of sodium fluoride and the peak serum fluoride concentration that will allow an estimate of the margin of safety of the procedure.

Condition or disease Intervention/treatment Phase
Healthy Device: Fluoride varnish Early Phase 1

Detailed Description:

Fluoride varnish painted on the teeth is the standard method dentists use to prevent tooth decay (cavities) in preschool children in the United States. Fluoride varnish is not FDA approved specifically for prevention of cavities, but dentists may legally use it for this purpose. We want to study how much fluoride appears in the urine after the painting procedure to improve our knowledge of how the varnish works and its safety. The fluoride varnish is being used for research purposes for this study by permission of FDA (IND #110869).

Premier Dental Product Company's Enamel Pro Varnish will be used. Up to six children aged 12-15 months will be enrolled in this study. We measured urinary fluoride for 5 hours after application of fluoride varnish to teeth. Baseline levels were measured on a separate day.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 6 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Device Feasibility
Official Title: Fluoride Administered and Retained After Topical Fluoride Varnish
Study Start Date : December 2011
Actual Primary Completion Date : March 2013
Actual Study Completion Date : December 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Fluoride varnish
Topical fluoride
Device: Fluoride varnish
Topical application of fluoride varnish on present teeth
Other Name: Premier Enamel Pro



Primary Outcome Measures :
  1. Urinalysis for fluoride levels [ Time Frame: 2 days ]
    We want to study how much fluoride appears in the urine after the painting procedure to improve our knowledge of how the varnish works and its safety.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Months to 15 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • consent obtained from parent or legal guardian of participant
  • children aged 12 - 15 months
  • at least 1 erupted tooth
  • in general good health

Exclusion Criteria:

  • known allergy to any drug, latex, nuts, or resin components or components of toothpaste/dental prophylaxis product
  • participant has stomatitis or other oral conditions that preclude applying fluoride varnish comfortably

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01754831


Locations
United States, Washington
UW Center for Pediatric Dentistry
Seattle, Washington, United States, 98115
Sponsors and Collaborators
University of Washington
Investigators
Principal Investigator: Peter Milgrom, DDS University of Washington

Publications:
Responsible Party: Peter Milgrom, Professor, University of Washington
ClinicalTrials.gov Identifier: NCT01754831     History of Changes
Other Study ID Numbers: 41117
First Posted: December 21, 2012    Key Record Dates
Last Update Posted: May 7, 2018
Last Verified: May 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Peter Milgrom, University of Washington:
children
fluoride varnish

Additional relevant MeSH terms:
Fluorides
Fluorides, Topical
Cariostatic Agents
Protective Agents
Physiological Effects of Drugs